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Abstract 
Consumer involvement or patient and public involvement (PPI) in health research is a UK policy 
imperative and a prerequisite for many funders. PPI in research is defined as research carried out 
with or being carried out by the public (or service users), rather than research on patients and public 
as subjects or participants. Despite the clear policy driver, there is relatively little empirical evidence 
on the extent, processes and impact of user involvement in research. This paper aims to add to the 
international evidence base on PPI in research by providing a key overview of current trends and 
impacts. In order to understand the current extent and variation of PPI in research, a scoping 
exercise and survey were carried out on selected UK studies. Six research topic areas (cystic fibrosis, 
diabetes, arthritis, dementia, intellectual and developmental disabilities, and public health) were 
selected to ensure a range of designs, study populations and histories of PPI in research. A total of 
838 studies (non-commercial studies and not older than 2 years) were contacted. The response rate 
for the scoping was 38% and the survey 28%. In the scoping, 51% of studies had some evidence of 
PPI and in the survey 79%. The most common PPI activity was steering committee membership and 
reviewing patient information leaflets. There appeared to be some blurred roles with patients 
participating as research subjects as well as carrying out patient involvement roles. A major finding 
was the limited amount of available information about PPI in publicly accessible research 
documents. We suggest that the invisibility of this type of involvement and the lack of routinely 
collected information about PPI results in a lack of shared understanding of what optimal PPI in a 
study should look like, with important implications for practice. Furthermore, without a framework 
to review PPI it is difficult to know if different approaches to PPI have a different impact on key 
outcomes of the research. 
Keywords User, patient and public involvement, health research, consumer involvement, research 
policy. 
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Introduction 
Globally, there has been an increasing recognition of the importance of involving patients as 
consumers of health services and the public in healthcare governance and research (World Health 
Organization, 2005; Boivin et al., 2010). In the UK, evidence of consumer involvement in research is a 
policy imperative and a prerequisite for English National Institute for Health Research (NIHR) and 
other common sources of medical research funding, and for National Health Service (NHS) Research 
Ethics approval (Barber et al., 2012; Staley et al., 2012). Consumer involvement in research is defined 
as research with or being carried out by the public, rather than patients and the public being 
researched as participants (INVOLVE, 2012). Previous studies have identified a range of impacts of 
consumer involvement in research (Brett et al., 2010) including improving relevance, 
appropriateness and conduct of research; refining research questions; ensuring the acceptability of 
the design to research participants; bringing personal benefits to members of the public involved; 
contributing to ethical debates; and ensuring research meets policy targets (Entwistle et al., 1998; 
Staniszewska et al., 2007; Smith et al., 2008; McKevitt et al., 2009; Staley, 2009; Howe et al., 2010). 
However, despite repeated assertions of the benefits of consumer involvement for research, there is 
limited empirical support for its impact (Brett et al., 2010). What there is, has been criticized as 
poorly reported (Staniszewska et al., 2011b) or methodologically weak, often failing to fully explore 
the contextual factors surrounding consumer involvement as a complex intervention (Staniszewska 
et al., 2011a). There is also a focus on process often to the exclusion of defining or measuring the 
outcomes of consumer involvement (Kreindler, 2009). This paper reports findings from the first two 
phases of the RAPPORT study, which evaluated processes, mechanisms, context and outcomes of 
consumer involvement in UK health research. This first two stages of the study comprised of a 
scoping and survey to gain an indication of the current level of consumer involvement across six 
health research topic areas, and provide a sampling frame for the subsequent third in-depth case 
study phase. Although there is policy support for consumer involvement, there are few studies that 
have explored the extent and nature of patient and public involvement (PPI) activity in research. 
Background 
The claims made for consumer involvement as a contributor to improved quality and outcomes of 
health research are underpinned by one of the three paradigmatic stances on consumer 
involvement. These are methodological, the moral and ethical, and the political. The methodological 
argument (Telford et al., 2002; Ward et al., 2010), which Boote et al. (2011) called the 
consequentialist argument, suggests that consumer involvement has the potential to not only 
improve quality and impact of research, but also improve accountability of researchers and make 
the research process more transparent. However, defining consumer involvement outcomes solely 
in terms of research quality ignores the rights of those being researched or likely to benefit from the 
research to be involved in how it is defined and executed (McKevitt et al., 2009). In addition to the 
methodological stance, there is a moral and ethical perspective that identifies consumer 
involvement as a right for the tax-paying citizen within a democratic society (Ward et al., 2010). 
Involvement as a right is a stance informed by the belief that consumer involvement is empowering 
for the individual and communities, and gives voice to marginalized people and communities (Barnes 
et al., 2004). The third perspective is the political value of consumer engagement as a means of 
enhancing the validity of decision making and policy development (Barnes et al., 2004). The health 
research community is socially constructed and framed by precepts largely drawn from the medical 
community (Jordan and Court, 2010). The differing terms used for consumer involvement are 
derived from the dominant discourse within each context and social group, and within UK health 
research the term PPI is more commonly used than consumer involvement. There is an inherent 
tension between the connotations of passivity implied by the word patient and the proactive nature 
of involvement (Wilson, 2001; Jordan and Court, 2010); however, to reflect common usage, we will 
use the term of PPI throughout the rest of the paper. 
The national infrastructure of health research has increasingly supported PPI (Department of Health, 
1999, 2005; National Institute of Health Research, 2013), and there is evidence that PPI is influenced 
and shaped by local initiatives (Howe et al., 2010) and their histories (Purttell and Gibson, 2012). 
Hence, it cannot be assumed that there is a shared definition of PPI or a shared approach. The 
multifaceted world of PPI with its range of context, social groups, assumptions, values and 
constructions (Staniszewska and Denegri, 2013) requires a methodological approach capable of 
capturing complexity that can address questions of what kind of PPI works in what kind of settings or 
structures with what kind of outcomes?  
Methodology 
The overarching framework of the study was guided by a realist evaluation (Pawson and Tilley, 2001) 
to explore how PPI might work best, under what circumstances and for whom. The study sought to 
evaluate how different approaches to public involvement in research with different populations 
influence the identification of priorities, research conception, design, process, findings and 
knowledge transfer. This paper reports findings from the first two phases of the study (scoping and 
survey), where the aims were to determine the variation in types and extent of public involvement 
in six selected research topic areas of funded research. The findings from these phases were used to 
develop a sampling frame for the final case study phase. To ensure a range of research foci and to 
capture a range of approaches to PPI, we identified six topic areas with different patient 
populations: cystic fibrosis (CF), diabetes, arthritis, dementia, intellectual and developmental 
disabilities (also known as learning disabilities), and public health. The topic areas were purposively 
selected to represent a diverse range of studies and associated PPI. This included studies with 
participants recruited across the lifespan (e.g. children and young people in CF studies, and older 
people in dementia studies), research designs (basic science to qualitative), settings (acute care, 
primary care), and different traditions and history of PPI. For example, diabetes has a strong national 
patient organization with a record of being involved in research and commissioning of health 
services. Both diabetes and dementia have a national research infrastructure that has well 
established PPI mechanisms (Matthews et al., 2007; Iliffe et al., 2011), and the intellectual and 
developmental disabilities community at both policy and research levels has focused on inclusive 
practice (Department of Health, 2009). Public health was included to include community 
interventions and user-led projects and local populations who may not consider themselves as 
patients. In the UK, clinical research networks have been established in each of the four UK nations 
funded by the UK health departments. These national networks form the UK Clinical Research 
Network (UKCRN). The UKCRN portfolio of studies was used as one single database to identify 
relevant research studies, and information including study title, sample size, end date of recruitment 
and contact details were downloaded into an Excel spreadsheet. For search terms, see Table 1. 
To ensure inclusion of studies most likely to have been designed since the embedding of PPI in the 
research governance framework (Department of Health, 1999), we excluded studies that were more 
than 2 years old (end date of recruitment before 1 September 2009). We also excluded studies that 
were funded by commercial organizations because despite current criticisms of the lack of 
transparency in drug trials (Thompson and Heneghan, 2012; Chalmers et al., 2013), access to study 
documents was likely to be limited. In total, 1464 studies in the six broad topic areas were 
downloaded from the UKCRN database. One hundred and two were excluded as not in the specific 
topic areas, more than 2 years old (n = 263) or commercially funded (n = 261). A total of 838 studies 
were included (Table 2). 
Table 1 Search terms for topic areas accessed on UKCRN portfolio 
 
Topic area   Search terms 
 
Cystic fibrosis   Keyword ‘cystic fibrosis’ 
Diabetes    Type 1 and type 2 and other 
Arthritis    Musculoskeletal, inflammatory and immune, genetics, primary care 
Dementia  Dementia and neurodegenerative diseases, Huntington’s disease, motor neurone disease, 
Parkinson’s disease, other  
Intellectual and  Searched on keywords: ‘learning’, ‘attention’, ‘Downs’, intellectual’, ‘autism’, ‘Asperger’. Mental 
developmental   health: learning difficulties theme. 
disabilities  Specific syndromes listed on http://www.rcpsych.ac.uk/pdf/clinical%20syndromes%20 
associated%20with%20learning%20disability.pdf 
Public health   Primary care, infection, keyword ‘public health’ 
All topics    Generic relevance and cross-cutting themes 
 
UKCRN, UK Clinical Research Network. 
 
 
Table 2 Search of UKCRN portfolio in six topic areas 
 




Number of studies identified on  
UKCRN portfolio  23   512  399  282  90   158   1464 
Number of studies  
for inclusion     8   277  188  192  51   122     838 
% of total on UKCRN  35     54    46    68  57     77       57 
 
UKCRN, UK Clinical Research Network. 
 
In order to determine the variation in types and extent of PPI in the six topic areas, our aim was to 
carry out an initial scoping exercise on PPI information within the documentation available on each 
study. Variation in PPI was mapped against the type of research, topic area and funding body. A 
scoping framework (Table 3) based on Brett et al.’s (2010) systematic review and Oliver et al.’s 
(2008) conceptual framework was used in an attempt to gather information about PPI and assess 
the stages of the research where PPI occurred, the model of PPI used (e.g. lay panel or individual 
service user) and where it was located on a continuum from user-led research to minimal PPI. 
The scoping phase (October to December 2011) was followed by an online survey (January to 
February 2012) of chief investigators. 
The design of the survey was drawn from Boote et al.’s (2006) indicators of successful PPI including 
roles, resources, training and support, and recruitment. Four geographical regions in England were 
purposively selected for the survey to ensure maximum variation: the South West has a relatively 
large rural population and a long history of PPI (Purttell and Gibson, 2012), the East of England has 
established PPI networks (Howe et al., 2006) with rural and urban areas, whereas there is less 
evidence of a long-established PPI history in the North East, which has one major research hub and 
the associated impact on socio-economic factors of having a heavily industrialized past. London is 
the most densely clustered in terms of research centres and has a relatively high population of 
people from black and minority ethnic groups. The aims of the survey were to explore the key 
processes, mechanisms and the contextual dynamics of PPI in research, and to identify barriers and 
enablers to effective PPI in research. 
Within the initial scoping exercise, we found that there is minimal direct access to study 
documentation. Additionally, even when the protocol was available on the funder’s or study web 
site, there was little information about PPI. Therefore we also contacted study teams directly or via 
collaboration with the Association of Medical Research Charities for PPI information. For studies not 
covered by the online survey (i.e. running outside of the four geographical regions including 
Scotland, Wales and Northern Ireland; Fig. 1), direct requests were made. Documents or email 
replies were then reviewed by two team members independently for background study information 
and any evidence of the nature, extent and activities of PPI. 
Scoping exercise: response and study characteristics 
The scoping exercise obtained information about PPI from 182 studies out of a possible total of 478 
(38%) (Table 4). Documents received in response to requests for PPI information included 93 
protocols, 12 journal articles, 64 email replies, 10 interim/final reports and 3 Integrated Research 
Application Service (IRAS) forms. Other documents (such as grant applications, reports to funders, 
lay summaries) were also provided. Some studies provided more than one source of information. 
The studies in the scoping had sample sizes ranging from 12 to 250 000 with a median of 250. The 
two main funders were NIHR (29%) and charities (29%). The remaining funders were a mix of 
government departments, European Union, research councils and others. Forty-two percent of the 
scoping studies were clinical trials, a third were mixed methods (qualitative and quantitative non-
clinical trials), a tenth were basic science and 15% tissue bank/database. 
 







Institutional setting (university, NHS) 
End date (UKCRN) 
Open/closed recruitment (UKCRN) 
Type of document (protocol, article, IRAS, report, email, other) 
Main source document of PPI information (coverage) 
Evidence of PPI 
Number of PPI 
Reason for no PPI 
PPI activities (steering committee, patient information leaflets, data analysis, etc.) 
Number of PPI activities 
PPI recruitment 
Type of PPI (younger people, over 65, general public, etc.) 
Capacity of involvement (person with prior experience of disease, established PPI group, charity, 
etc.) 
Training 
Costing (travel, expenses, honorarium) 
Assessment of public engagement (lay controlled, collaborative, consultation, minimal) 
Assessment of researcher engagement (inviting lay groups, inviting lay people, responding to lay 
action, minor partner or absent) 
Impact of PPI 
Knowledge, use and scope of regional and local public involvement groups 
 
IRAS, Integrated Research Application System; NHS, National Health Service; PPI, patient and public 
involvement; UKCRN, UK Clinical Research Network. 
 Survey: response and study characteristics 
Across the four regions 360 studies were identified on the UKCRN portfolio from which the survey 
was emailed out to all named chief investigators or researchers. From the first email there was a 
17% response rate, and after the second reminder a total of 101 responses to the survey (28% 
response rate) (Table 4). The 101 studies surveyed included sample sizes ranging from 5 to 300 000, 
and grants awarded ranged from 8% of studies that received less than £50 000 (8%) to 30% of 
studies that were granted over £1 000 000. Funding was split quite evenly between NIHR (40%) and 
charities (40%). The survey included two-fifth clinical trials, a third quantitative and qualitative, 12% 
basic science and 7% tissue/bank database, and a further 7% were coded other (as insufficient 
information to classify). 
Findings 
Results from both the scoping exercise and survey suggested some common themes around PPI in 
research including limited information, lack of a clear definition, differences in approaches, 
challenges and impact. 
Limited information about PPI 
Currently, there is no mention of PPI found in UKCRN study information in the six topic areas. Nine 
funding web sites were searched, and open access to protocols was found to be very limited. The 
scoping exercise identified open access to study protocols on some funding web sites such as the 
NIHR Health Technology Assessment programme and some PPI information; otherwise, other 
funding web sites had very limited information. 
Overall, the responses to the scoping requests showed that 51% of studies had some evidence of PPI 
in the documents supplied, and 79% answered positively that they had PPI in the survey. The 
protocols obtained confirmed the website findings that there was little space or official requirement 
to record PPI, with only one third of protocols including any PPI information. Some respondents 
explained that other forms such as funding applications and IRAS forms had more detail of PPI. 
We are happy to share our information on PPI. As the protocol does not reflect the level of PPI in the 
design and conduct of the study I have highlighted fields from our original NIHR RfPB application 
form which reflect our level of PPI – see below. (Scoping: Arthritis: ID:S49) 
Researchers acknowledged that PPI is a relatively recent expectation from funders, and older studies 
may therefore have less. For some studies the external expectation was key to the development of 
PPI. 
We have had no structured PPI for this study. There are a number of reasons for this: The study was 
developed a while ago and there was less of an expectation for PPI. (Scoping: Diabetes Email 
Response: ID:S24) 
Defining PPI 
Various interpretations of PPI were apparent. As a reminder to recipients, the scoping requests for 
information and survey highlighted the INVOLVE definition (Staley, 2009) of PPI. Although some 
respondents stated that their study included PPI, this was not corroborated by their other comments 
and in some instances suggested that they had misunderstood the term PPI. For example: Question: 
In your opinion at what stage of the research does service user/public involvement have the most 
impact? ‘patient completes the questionnaires. Results help to understand/control disease in 
specific population’. (Survey: Public Health: ID81) In the scoping there were six studies where it was 
not clear whether what was being described was actually PPI, and these were excluded from the 
overall analysis. Similarly, the survey revealed a small number (n = 3) where respondents answered 
‘yes’ to having PPI in the study, but their answers to other questions suggested they meant their 
study recruited participants. In addition, an ‘uncertain’ or ‘dual role’ category was also created to 
cover four survey responses appearing to describe a role that blurred participants and public 
involvement. This emerging model of a dual role included examples of service users being consulted 
initially to refine study materials (perhaps within a focus group) and then subsequently being asked 
to join the study; involvement followed by participation. Some studies have participants who give 
feedback to the study while they are still participating in the trial: 
 
Figure 1 Flow diagram of scoping and survey. PPI, patient and public involvement; UKCRN, UK 













Table 4 Scoping and survey response rate by topic area. 
 
Scoping response rate    Survey response rate 
 
Cystic fibrosis    40% (n = 2/5)     67% (n = 2/3) 
Diabetes    34% (n = 46/137)    20% (n = 28/140) 
Arthritis    42% (n = 55/132)    25% (n = 14/56) 
Dementia    38% (n = 35/93)    31% (n = 31/99) 
Intellectual and    38% (n = 11/29)    23% (n = 5/22) 
developmental disabilities  
Search UKCRN portfolio database 
[to identify current studies or those completed 
in the last 2 years] 
(since 01 September 2009 and non-commercial 
studies) 
 
Studies located in four geographical 
regions of England (North East, 
London, East of England and South 
West) (n=360) 
Outside four geographical 
regions (n=478) 
Online survey 
UKCRN portfolio: link for protocol request 
Protocol available on funder’s or study web site 
On authors’ behalf, funder requests PPI 
information from study team 
Email 
Download 
Authors’ directly approach chief investigator for 
protocol and PPI information 
Email 
Email 
Public health    40% (n = 33/82)    53% (n = 21/40) 
Total     38% (n = 182/478)    28% (n = 101/360) 
We are continually listening to the comments of our participants in relation to study material and 
where possible modify accordingly. At the end of all the sessions they are asked to complete a 
feedback form with their comments. 
(Survey: Public Health: ID93) 
Depending on the research topic, it was suggested that PPI representatives should not be thought 
solely in terms of patients and the general public: 
The position that ‘service user’ is only defined as patient or carer. Some of my research is focused on 
different layers of NHS staff, and back-office work, so in this context, we need a much broader 
definition, that include service users beyond only patients/carers. (Survey: Arthritis: ID37) 
Differences in the reported presence of PPI 
There were differences in how PPI was approached by research topic and study design. Numbers of 
studies in some topic areas were very small (i.e. CF). In both the scoping and the survey, intellectual 
and developmental disabilities studies, compared with the other topic areas, had the highest 
percentage of PPI (scoping 91%; survey 100%) (Table 5). Second highest was arthritis (60%) in the 
scoping and dementia in the survey (87%). However, in the survey there was an overall trend for 
much higher levels of PPI across all topic areas than in the scoping. 
Using the IRAS definitions of study design, studies with the highest amounts of PPI had mixed-
method design (scoping 61% of studies with this design had PPI; survey 91%), followed by clinical 
trials (scoping 56%; survey 81%), which both had higher levels of PPI than basic science (scoping 
21%; survey 67%), tissue bank (scoping 33%; survey 43%) and other (observational studies and 
‘cohort’). Basic science or tissue bank design studies appear to have a limited role for PPI. However, 
the survey findings for the three topic areas of arthritis, dementia and public health showed 
examples of all four types of study design, and in these topic areas even basic science and tissue 











Table 5 PPI involvement in research studies by topic area 
 
Topic area     Scoping     Survey 
Cystic fibrosis     100% (n = 2)     0 
Diabetes     41% (n = 19)     79% (n = 22) 
Arthritis     60% (n = 33)     79% (n = 11) 
Dementia     34% (n = 12)     87% (n = 27) 
Intellectual and    91% (n = 10)     100% (n = 5) 
developmental disabilities 
Public health     49% (n = 16)     72% (n = 15) 
Total      51% (n = 92)     79% (n = 80) 
 
PPI, patient and public involvement. 
need to build and sustain good relationships with patient groups in order to identify priorities and 
gain the research materials they needed: . . . all our work has been carried out in partnership with 
the families. . . . often helps to focus what patients with a condition find most urgent to improve. 
(Survey: Diabetes: Basic Science Study: ID05) In this project probably all stages, from literature 
aimed at recruiting potential brain donors to lay people on the committee that gives ethical approval 
to researchers requesting tissue from the bank. We also invite a potential donor/carer to speak 
about brain donation from a personal perspective at our Ethics Training Days and this is always very 
highly rated by people contributing to brain donation, especially those without participant contact, 
such as mortuary services and neuropath lab staff. (Survey: Dementia: Research Tissue Bank: ID54) 
The influence of funders could also be seen in that higher levels of PPI were found in NIHR-funded 
studies (scoping 75%; survey 89%) and charity-funded studies (scoping 58%; survey 78%). Neither 
scoping nor survey found any relationship between sample size or geographical area and levels of 
PPI. There were a similar proportion of studies having PPI in the older studies (as measured by being 
‘closed’ on the UKCRN portfolio) as the open studies. These findings suggest that funder 
requirements and study design appear to be the biggest influence on the extent of PPI within a 
study. 
The extent of PPI activities within studies 
The scoping and survey listed nine possible activities that patients or the public could be involved in: 
• identify research topic; 
• design research methodology; 
• develop patient information leaflets; 
• data collection; 
• data analysis; 
• report writing; 
• advisory/steering committees; 
• review of reports and lay summaries; 
• dissemination activities (plus other). 
 
Table 6 Patient and public activities in research 
 
PPI activities     Scoping    Survey 
%     % 
 
Advisory/steering committee    65     71 
Development of participant   35     73 
information materials 
Dissemination of materials    16     49 
Review of reports/lay summaries     8     48 
Design of research methodology   62     45 
Identification of research topic    17     21 
Report writing        3       9 
Data analysis      12       8 
Data collection        3       6 
Other       10     10 
 
PPI, patient and public involvement. 
The most frequently represented PPI activity was being on an advisory/steering committee (65% in 
the scoping study) and patient information leaflet development (73% in the survey) with low levels 
of involvement in data analysis, data collection and report writing in either (see Table 6). 
The possible nine activities were then totalled into a score, and the survey revealed that learning 
disability, followed by arthritis and dementia had the highest median level of activities (4.0 for 
intellectual and developmental disabilities, and 3.0 for arthritis and dementia). However, Fig. 2 
shows that there is little difference in the overall range of activities between each topic area. 
Identification and recruitment of PPI members 
The survey showed that the half (50%) of PPI representatives involved in research projects were 
patients or service users known to the researcher/clinician, and that very few were recruited via 
their local NHS comprehensive local research network or research design service. PPI 
representatives were also recruited via voluntary organizations (40%) or from an established service 
user group (35%), and a quarter (25%) had replied to an open invitation (respondents could choose 
more than one option). Twenty-nine percent of studies had 21 or more individual patient or public 
representatives involved. However, the PPI information in the scoping documents/emails was very 
limited, and it was difficult to access who the PPI members were, how many there were and how 
they had been recruited. It was therefore not possible to make an accurate assessment about PPI 
models. Just over a third gave any information about PPI recruitment, and only around a quarter of 
the studies gave any information about the number of PPI representatives. Although the scoping 
found evidence of the provision of training for PPI representatives in 9% of the studies, over a 
quarter (28%) of studies with PPI in the survey had provided training for their PPI members, and 43% 
had been directly costed for in the grant application. 
The challenges and limitations of PPI 
Through the means of an open-ended question survey respondents were asked for their views on 
the challenges and limitations of PPI in their study. Findings proved to raise similar issues to some of 
the ‘dissenting voices’ reported by Boote et al. (2002), such as representativeness. The challenges 
identified were recruitment, communicating the research to lay people, extra resources needed,  
 Box 1 Survey: main theme: challenges of recruitment 
Trying to get a representative sample and not just the usual suspects. (Dementia: Qualitative 
Studies: ID50) 
The only challenge is in finding appropriate representatives, they need to be able to understand 
the basics of the type of research that you doing but if they are all former academics and/or 
health professionals it kind of defeats the purpose, we were fortunate to get a mixture. (Dementia: 




Figure 2 Survey: boxplot of number of activities for those studies with PPI, by topic, showing the 
range of the number of activities, 75th percentile, median and 25th percentile.  










the potential for tokenism, bureaucracy, confidence of individuals to participate, managing 
expectations of the PPI individuals and threats to long-term commitment (such as illness). The most 
common theme that emerged was recruitment and how to gain access to ‘representative’ services 
users, mentioned by about one third of respondents (Box 1). 
These comments may suggest that some researchers feel that the PPI representatives currently 
volunteering for research studies are not necessarily those they feel should be involved or are not 
authentically representing the views of others, or do not offer enough diversity, and that recruiting 
PPI members was challenging. 
Key: 
a – Maximum value 
b – 75th percentile 
c – Median 
d – 25th percentile 
e – Minimum value 































































There was also some evidence of concern about PPI representatives losing the service user 
perspective through a process of socialization into the research world: In some contexts, we are 
engaging with a cadre of service users/public that become ‘professionalised’, that they are being 
repeatedly asked to speak for others. (Survey: Arthritis: ID37) 
In addition to recruitment issues, the next most common challenge highlighted by researchers was 
being able to communicate their research (i.e. complex design) to lay people and the time (to 
comment and build relationships) and resources required to make the research accessible and 
supportive of PPI. Researchers were also aware of the challenge of involving the public in a 
meaningful and real’ way. The management of expectations as to what the study could deliver was 
mentioned by some researchers, and reconciling the sometimes competing priorities of researchers 
and PPI representatives. This is a particular issue in research that might not bring benefits in the 
lifetime of the PPI representatives. 
Mainly the wish of families to believe that the genetic, clinical or cell studies will provide rapid 
answers and treatments. (Survey: Diabetes: Basic Science: ID05) 
The research approach did appear to influence what particular aspects of PPI were highlighted by 
respondents as challenging. Topic-specific issues were mentioned, with dementia studies identifying 
the extra time needed for PPI, and diabetes studies the need to clearly explain information about 
the research. These findings point to certain topic areas and study designs having different needs 
and challenges for researchers when working with PPI representatives. 
Impact of PPI 
Few studies provided any examples of impact: this is possibly due to the fact that protocols are 
written at the beginning of the study, and until recently there has been little formal requirement to 
record potential or actual PPI impact in routine research documents. 
More recently, there has been a growing emphasis on making attempts to assess the impact of PPI 
(Staley, 2009; Brett et al., 2010; Barber et al., 2011; Barber et al., 2012; Staley et al., 2012). 
This survey included an open question where respondents could write about which stage they felt 
PPI had the most impact. The most frequent type of answer given was ‘the design stage/at the 
beginning/as early as possible’. Studies that were clinical trials had the highest proportion of 
respondents naming PPI as having the most impact at the design stage. The next most frequent was 
‘at every stage’, and mixed methods had a higher proportion of respondents naming PPI as having 
the most impact at all stages.  
To elicit any embedded PPI practices, the respondents with PPI in their study were asked if working 
with regional/local public involvement groups had altered their practice when writing proposals. 
Seventy-nine percent of researcher respondents said they knew of a local or regional and public 
group that had supported research. Of the 63% who had used such a group, 36% (29) said that this 
group had altered their practice when writing the proposal.  
The main way in which the researchers said they had altered their practice had been by consulting 
PPI at proposal writing stage to ‘define research questions’ and making objectives ‘more realistic’ 
and ‘patient orientated’. 
Discussion 
Few previous studies have evaluated PPI in research across topic areas and study design. Two 
surveys conducted 13 (Telford et al., 2002) and 11 years ago (Barber et al., 2007) attempted to 
quantitatively capture the extent of PPI in English health research. 
Telford et al.’s (2002) survey of 66 NHS research and development leads had a 73% response rate, 
but less than 25% reported any PPI in research activity within their respective NHS organizations. 
Barber et al.’s (2007) survey was conducted 2 years later and comprised of a randomly selected 
sample of 900 researchers from the National Research Register. Their response rate of 58% had an 
even lower report of PPI activity in research, with only 17% stating there was PPI in their research 
studies. Hence, our survey findings with 79% respondents reporting there was PPI in their research 
study show a significant increase in the extent of PPI activity. This is unsurprising given that there has 
been a successive flow of national policies aimed at increasing and embedding PPI in research 
(Department of Health, 1999, 2005, 2006; National Institute of Health Research, 2011). Major 
research funders now expect to see details of PPI in the grant application and this was reflected in 
our results where NIHR-funded studies (which require PPI details) were more likely to confirm the 
presence of PPI. 
Despite these encouraging findings indicating that PPI in research is becoming more widespread in 
England a number of limitations persist. A major finding was the limited amount of publically 
accessible information about PPI within research documents, despite PPI becoming a requirement 
by many funding agencies. Although the expectations of the funder was identified as a key influence 
on PPI within grant applications and study designs, not only was there a lack of transparency within 
documentation about how PPI would be operationalized, but equally there appeared to be a lack of 
follow through reflecting some of the problems in the quality of reporting PPI more generally in 
studies (Staniszewska et al., 2011b). Hence, although PPI processes may be articulated within grant 
applications, there is no documentation providing evidence of monitoring or how the PPI strategy 
within a study may have changed as the research develops. This provides a stark comparison to 
other amendments in study protocols that undergo rigorous and transparent external monitoring 
and auditing of research governance. 
There were some differences in PPI by topic area and study design. The findings support the 
generally held assumption that certain study designs (qualitative and quantitative) tend to lend 
themselves to PPI. However, basic science and tissue bank studies can and do include PPI (Nierse et 
al., 2012); this would suggest that the variation of engagement observed is not related to particular 
study designs. Certain disciplines such as intellectual and developmental disabilities embedded 
within the ‘nothing about us without us’ approach demonstrated a synergy of the topic area 
paradigm and engagement with PPI in research. It would be worth investigating further if PPI is a 
proxy measure of disciplines commitment to public understanding, patient engagement and 
involvement in decision making. 
The survey suggested that PPI representatives were most often involved in steering committees and 
reviewing participant information leaflets, a similar finding to Barber et al.’s (2007) earlier survey. 
There were fewer examples of lay people being involved in report writing, data analysis and data 
collection. Although there appeared to be some basic assumptions around the numbers of lay 
representatives required to make PPI viable, of more significance than just numbers of PPI 
representatives within a study was the extent PPI was threaded throughout the study from design to 
dissemination. Nevertheless, accurate recording of how many PPI representatives have been 
consulted may provide an indication on the range of views included. Studies with one person on a 
steering committee may be quite a different type of lay involvement from studies consulting large 
panels of patients or people representing patients. 
A persistent issue is what effective PPI looks like. Pragmatism appeared to shape who was identified 
and how they were recruited, and as found in another study this may result in seeking retired 
academics who require little support (Ward et al., 2010) and are deemed as competent (Barnes et 
al., 2003). Arguably, the unintended consequence of this approach is to reinforce the views and 
priorities of patient groups who are white, articulate and middle class, and at worse support the 
inherent inequalities we know are present in healthcare delivery. Representativeness continues to 
be a vexed issue for the research community (Boote et al., 2011) and includes concerns around 
familiarity with the research process and discourse leading to loss of the lay perspective (Jordan and 
Court, 2010), in other words the professionalization of lay representatives (Ives et al., 2013). 
Depending on the researcher’s viewpoint, at one end of a continuum PPI is seen as the source of 
authentic insider knowledge (McKevitt et al., 2009) with a consequential desire to seek lay people 
with close direct experience of the topic area (Beresford, 2005). At the other end, professional 
knowledge is seen as the only valid epistemology (Ward et al., 2010). Our study demonstrated 
diverse definitions of PPI shaped by differing values (Kreindler, 2009) and reflecting the range of 
reasons given for PPI within studies. These reasons included ensuring the research asks the right 
questions of greatest interest to the population affected, to ensuring that recruitment targets are 
reached. 
Echoing Barber et al.’s (2007) earlier survey, our findings suggest that some researchers continue to 
have difficulty in distinguishing between research participation and PPI activities. Although some 
researchers appear not to understand the differences between involvement, engagement and 
participation in research (INVOLVE, 2012), there is also developmental evidence of some explicit 
merging of research participant and PPI roles, in which patients undertake a dual role as participant 
and also as lay representatives. With the current focus on increasing patient participation in research 
trials (Department of Health, 2011; National Cancer Research Institute, 2012) and given that 
involvement and participation are listed alongside each other in the NIHR’s aims for patient and 
public awareness of research, this may be an appropriate time to examine the potential advantages 
and implications of this dual role further. In particular, the ethical implications and the robustness of 
knowledge gained in this way need to be explored further. 
This study found no information routinely available on PPI in open access UKCRN portfolio. Largely 
due to space limitations and little routine recording of PPI, research study documents again 
contained limited information regarding PPI in their project. It could be suggested that funding 
agencies may wish to require the routine collection of more insightful information on PPI: not just 
whether the project has PPI or not, but its level and extent, the numbers and types of member 
involved, methods of recruiting them to the study, and the impact of PPI on processes and outcomes 
of the research by the end of the study. The perspective of PPI representatives involved in the study 
should be inherent within this reporting mechanism. Such routine recording may enable some 
effective systematic oversight and examination of what PPI currently constitutes. In many ways such 
data are essential in the continual development of the PPI evidence base.  
Limitations of the study  
The study has concentrated on six topic areas and aimed to compare any differences in approach to 
PPI. Basing data collection on the UKCRN portfolio will have excluded smaller charity funded projects 
or user-led projects; however, the portfolio does represent mainstream healthcare research. In 
addition, some numbers within a topic area are very low, making analysis/significant differences 
difficult to calculate. Although within normal parameters of an electronic survey, the response rate 
of 28% was low, and those answering the survey were more likely to be positive to PPI than those 
who did not. Nonetheless, the scoping and survey provide a useful snapshot of the current trends in 
PPI in UK. 
Conclusion 
Although PPI is now an expected component of all UK research studies, it is largely invisible in 
publicly accessible research study documentation, and many funders do not routinely collect 
information about PPI. The lack of detail and clarity about PPI has two consequences. There is no 
shared understanding of what optimal PPI in a study should look like or what a minimum level of 
engagement and representation should be. Second, the lack of transparency allows PPI to be defined 
by what the research team says it is. There is no framework for accountability or review, so it is 
difficult to know if different approaches to PPI have a different impact on key outcomes such as 
recruitment, generalizability and knowledge translation. The finding that PPI roles blurred with 
patient participation as research subjects suggests that without greater clarity about the purpose 
and contribution of PPI and possible ethical conflicts, challenges of tokenism will persist.  
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